Correlation between SMADs and Colorectal Cancer Expression, Prognosis, and Immune Infiltrates

Figure 6

Survival and prognosis analysis of SMADs in CRC patients (GEPIA). (f) SMAD6 and (h) SMAD9 were related to OS ( = 0.034,  = 0.016). (a) The OS and DFS of SMAD1 in CRC patients by GEPIA. (b) The OS and DFS of SMAD2 in CRC patients by GEPIA. (c) The OS and DFS of SMAD3 in CRC patients by GEPIA. (d) The OS and DFS of SMAD4 in CRC patients by GEPIA. (e) The OS and DFS of SMAD5 in CRC patients by GEPIA. (g) The OS and DFS of SMAD7 in CRC patients by GEPIA.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)